← All Sponsors
SPONSOR

Astellas Gene Therapies

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: X-Linked Myotubular Myopathy

Astellas Gene Therapies is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including X-Linked Myotubular Myopathy.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Astellas Gene Therapies

How many clinical trials has Astellas Gene Therapies sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Astellas Gene Therapies, of which 2 are actively recruiting participants. These trials cover conditions including X-Linked Myotubular Myopathy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Astellas Gene Therapies research focus on?
Astellas Gene Therapies clinical trials span X-Linked Myotubular Myopathy. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Astellas Gene Therapies clinical trial?
To participate in a Astellas Gene Therapies trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Astellas Gene Therapies trials with current recruitment status updated daily.

Clinical Trials by Astellas Gene Therapies

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology